前癃通胶囊治疗良性前列腺增生症临床观察及对人前列腺组织Bcl-2、Bax表达的影响
|
摘要
目的:1.观察前癃通胶囊治疗BPH的临床疗效。
2.检测前癃通对前列腺组织细胞凋亡指数及细胞周期的影响。
3.检测前癃通对前列腺组织bc1-2、bax表达的影响。
方法:
临床研究:对72例病例进行了临床观察。将72例BPH患者,采用随机数字表法分为治疗组和对照组,治疗组40例,口服前癃通胶囊,对照组32例,口服癃闭舒胶囊。观察患者的中医症侯评分,排尿症状评分,生活质量评分,并采用B超检测BPH患者的前列腺体积和膀胱残余尿量,用尿流计测最大尿流率。比较治疗前后两组患者症状及总有效率。
实验研究:
1.采用组织细胞培养法,体外对BPH患者的前列腺组织块进行培养。
2.采用TUNEL法,检测前癃通对体外培养BPH患者前列腺组织细胞凋亡指数的影响。
3.采用流式细胞术(FCM),检测前癃通药液对BPH患者前列腺组织细胞周期的影响。
4.免疫组化法检测前癃通对体外培养BPH患者前列腺组织bc1-2、bax蛋白表达的影响。
5.RT-PCR法检测前癃通对体外培养BPH患者前列腺组织块细胞bc1-2 mRNA、baxmRNA基因表达的影响。
结果:
临床研究:前癃通胶囊在减轻患者排尿症状、改善生活质量、提高最大尿流率、减少膀胱残余尿量等方面均明显优于癃闭舒(P<0.05),能缩小增生的前列腺体积,与治疗前比较差异有统计学意义(P<0.01)。在临床疗效方面,前癃通胶囊(92.5%)与癃闭舒胶囊(75.0%)相比,差异有统计学意义(P<0.01)。
实验研究:
1.药物前癃通能促进细胞凋亡,前癃通各剂量组的前列腺细胞凋亡指数都有不同程度上升,与模型组比较,差异有统计学意义(P<0.01),且对细胞凋亡的促进作用表现出明显的量效关系。同时前癃通药液使前列腺组织细胞的G_0/G_1期细胞数增加,与模型组比较差异具有统计学意义,对细胞周期的影响同样表现出明显的量效关系。
2.前癃通高、中剂量组对前列腺组织bc1-2蛋白、bc1-2 mRNA基因的表达有不同程度的抑制作用,对bax蛋白、bax mRNA基因的表达有不同程度的增强作用。
结论:1、前癃通胶囊在减轻排尿症状、改善生活质量、提高最大尿流率和减少膀胱残余尿量方面均有显著疗效,并能一定程度的缩小增生的前列腺体积,总疗效优于癃闭舒对照组。
2、前癃通对前列腺组织能促进细胞凋亡,同时使细胞周期发生G_0/G_1期阻滞,抑制bc1-2的基因表达,增强bax的基因表达,从而抑制前列腺增生。
Objective:1.Observe the clinical curative effect of Qian Long Tong capsule on treating Benign Prostate Hyperplasia(BPH).
2.Detect the influence of Qian Long Tong capsule on apoptosis index and cell cycle arresting of the prostatic stromal cells in BPH.
3.Explore the influence of Qian Long Tong on the expressions of bax, bcl-2 in prostatic tissue.
Methods:
Clinical observation:Seventy-two patients of BPH were divided into treatment group and control group according to random word method in the clinical observation.40 cases in treatment group were treated by Qian Long Tong capsule,32 cases in control group were treated by Long Bi Shu capsule.We observed the patients' scores of tcm symptom, urination symptoms and living quality,tested the patients' prostate volume and bladder remaining urine by B-ultrasound,and tested maximum urinary flow rate by urine flow meter.Results of the patients' symptoms and total effective rate were compared before and after treatment.
experimental research:
1.The prostatic cells of BPH and prostatic tissue mass were cultured in vitro.
2.TUNEL was used to examine the effect of Qian Long Tong herb liquor on expressions of apoptosis index.
3.Flow cytometry was used to observe the effect of Qian Long Tong herb liquor on cell cycle arresting.
4.1mmunity histochemistry analysis was used to explore the influence of Qian Long Tong herb liquor on the expressions of bcl-2 protein and bax protein in prostatic tissue mass.
5.RT-PCR was used to examine the effect of Qian Long Tong herb liquor on expressions of bcl-2 mRNA gene and bax mRNA gene.
Results:
Clinical observation:Qian Long Tong capsule raised the maximum urinary flow rate,improved the living quality,decreased bladder remaining urine,and alleviate sufferings of voiding symptoms,which are all much better than Long Bi Shu capsule(P＜0.05).And Qian Long Tong capsule can also reduce the prostate volume of hyperplasia,compared with pre-treatment(P＜0.01).There was a very significant difference of the clinical curative effect between the treatment group and the control group(P＜0.01).
Experimental research:
1.Qian Long Tong can promote the cells' apoptosis.The apoptosis index increased with different degree in different dose groups of Qian Long Tong,and there was a very significant difference among different dose groups with the model group(P＜0.01).There seemed to be an obvious dose-dependent relationship.And Qian Long Tong could induce G_0/G_1 phase arresting and seemed to be dose-dependent.
2.During high and medium dose groups of Qian Long Tong,there were different degree of inhibitory action on the expressions of bcl-2 protein and bcl-2 mRNA gene,while enhancement action on the expression of bax protein and bax mRNA gene.
Conclusion:1.Qian Long Tong capsule is obviously better than Long Bi Shu capsule in alleviating sufferings of voiding symptoms,improving the living quality,raising the maximum urinary flow rate,and decreasing bladder remaining urine;and Qian Long Tong capsule can reduce the prostate volume of hyperplasia.
2.Qian Long Tong can promote the cell's apoptosis and arrest the G_0/G_1 phase.And Qian Long Tong can inhibit the expression of bcl-2 gene, enhance the expression of bax gene thus inhibit the hyperplasia of prostate tissue.
2.检测前癃通对前列腺组织细胞凋亡指数及细胞周期的影响。
3.检测前癃通对前列腺组织bc1-2、bax表达的影响。
方法:
临床研究:对72例病例进行了临床观察。将72例BPH患者,采用随机数字表法分为治疗组和对照组,治疗组40例,口服前癃通胶囊,对照组32例,口服癃闭舒胶囊。观察患者的中医症侯评分,排尿症状评分,生活质量评分,并采用B超检测BPH患者的前列腺体积和膀胱残余尿量,用尿流计测最大尿流率。比较治疗前后两组患者症状及总有效率。
实验研究:
1.采用组织细胞培养法,体外对BPH患者的前列腺组织块进行培养。
2.采用TUNEL法,检测前癃通对体外培养BPH患者前列腺组织细胞凋亡指数的影响。
3.采用流式细胞术(FCM),检测前癃通药液对BPH患者前列腺组织细胞周期的影响。
4.免疫组化法检测前癃通对体外培养BPH患者前列腺组织bc1-2、bax蛋白表达的影响。
5.RT-PCR法检测前癃通对体外培养BPH患者前列腺组织块细胞bc1-2 mRNA、baxmRNA基因表达的影响。
结果:
临床研究:前癃通胶囊在减轻患者排尿症状、改善生活质量、提高最大尿流率、减少膀胱残余尿量等方面均明显优于癃闭舒(P<0.05),能缩小增生的前列腺体积,与治疗前比较差异有统计学意义(P<0.01)。在临床疗效方面,前癃通胶囊(92.5%)与癃闭舒胶囊(75.0%)相比,差异有统计学意义(P<0.01)。
实验研究:
1.药物前癃通能促进细胞凋亡,前癃通各剂量组的前列腺细胞凋亡指数都有不同程度上升,与模型组比较,差异有统计学意义(P<0.01),且对细胞凋亡的促进作用表现出明显的量效关系。同时前癃通药液使前列腺组织细胞的G_0/G_1期细胞数增加,与模型组比较差异具有统计学意义,对细胞周期的影响同样表现出明显的量效关系。
2.前癃通高、中剂量组对前列腺组织bc1-2蛋白、bc1-2 mRNA基因的表达有不同程度的抑制作用,对bax蛋白、bax mRNA基因的表达有不同程度的增强作用。
结论:1、前癃通胶囊在减轻排尿症状、改善生活质量、提高最大尿流率和减少膀胱残余尿量方面均有显著疗效,并能一定程度的缩小增生的前列腺体积,总疗效优于癃闭舒对照组。
2、前癃通对前列腺组织能促进细胞凋亡,同时使细胞周期发生G_0/G_1期阻滞,抑制bc1-2的基因表达,增强bax的基因表达,从而抑制前列腺增生。
Objective:1.Observe the clinical curative effect of Qian Long Tong capsule on treating Benign Prostate Hyperplasia(BPH).
2.Detect the influence of Qian Long Tong capsule on apoptosis index and cell cycle arresting of the prostatic stromal cells in BPH.
3.Explore the influence of Qian Long Tong on the expressions of bax, bcl-2 in prostatic tissue.
Methods:
Clinical observation:Seventy-two patients of BPH were divided into treatment group and control group according to random word method in the clinical observation.40 cases in treatment group were treated by Qian Long Tong capsule,32 cases in control group were treated by Long Bi Shu capsule.We observed the patients' scores of tcm symptom, urination symptoms and living quality,tested the patients' prostate volume and bladder remaining urine by B-ultrasound,and tested maximum urinary flow rate by urine flow meter.Results of the patients' symptoms and total effective rate were compared before and after treatment.
experimental research:
1.The prostatic cells of BPH and prostatic tissue mass were cultured in vitro.
2.TUNEL was used to examine the effect of Qian Long Tong herb liquor on expressions of apoptosis index.
3.Flow cytometry was used to observe the effect of Qian Long Tong herb liquor on cell cycle arresting.
4.1mmunity histochemistry analysis was used to explore the influence of Qian Long Tong herb liquor on the expressions of bcl-2 protein and bax protein in prostatic tissue mass.
5.RT-PCR was used to examine the effect of Qian Long Tong herb liquor on expressions of bcl-2 mRNA gene and bax mRNA gene.
Results:
Clinical observation:Qian Long Tong capsule raised the maximum urinary flow rate,improved the living quality,decreased bladder remaining urine,and alleviate sufferings of voiding symptoms,which are all much better than Long Bi Shu capsule(P＜0.05).And Qian Long Tong capsule can also reduce the prostate volume of hyperplasia,compared with pre-treatment(P＜0.01).There was a very significant difference of the clinical curative effect between the treatment group and the control group(P＜0.01).
Experimental research:
1.Qian Long Tong can promote the cells' apoptosis.The apoptosis index increased with different degree in different dose groups of Qian Long Tong,and there was a very significant difference among different dose groups with the model group(P＜0.01).There seemed to be an obvious dose-dependent relationship.And Qian Long Tong could induce G_0/G_1 phase arresting and seemed to be dose-dependent.
2.During high and medium dose groups of Qian Long Tong,there were different degree of inhibitory action on the expressions of bcl-2 protein and bcl-2 mRNA gene,while enhancement action on the expression of bax protein and bax mRNA gene.
Conclusion:1.Qian Long Tong capsule is obviously better than Long Bi Shu capsule in alleviating sufferings of voiding symptoms,improving the living quality,raising the maximum urinary flow rate,and decreasing bladder remaining urine;and Qian Long Tong capsule can reduce the prostate volume of hyperplasia.
2.Qian Long Tong can promote the cell's apoptosis and arrest the G_0/G_1 phase.And Qian Long Tong can inhibit the expression of bcl-2 gene, enhance the expression of bax gene thus inhibit the hyperplasia of prostate tissue.
引文
[1]中华人民共和国卫生部制定发布.中药新药临床研究指导原则(第三辑)[S].1997:54-57.
[2]国际协调委员会有关前列腺疾病患者诊断和治疗方法的推荐意见[J].中华泌尿外科杂志,1997,9(3):230-235.
[3]吴阶平.泌尿外科学[M].济南:山东科学技术出版社,2005,1125-1172
[4]鄂征,组织培养和分子细胞学技术[M],北京:北京出版社,2001:35-38
[5]司徒镇强,吴军正.,细胞培养[M],西安:兴界图书出版,2003:22-77
[6]孙明,杨宇如,李虹,等.多西紫杉醇对激素非依赖性前列腺癌的体内外作用研究[J],中国男科学杂志,2004,18(5):14-16
[7]刘文革,林佳俊,王锋等,RT-PCR检测bFGF对脊髓损伤后bcl-2、bax基因的表达[J],福建医科大学学报,2005,39(3):281-283
[8]柯梦笔,前列平胶囊治疗前列腺增生46例[J],广西中医药杂志,1996,17(2):22
[9]鲍镇美,良性前列腺增生的药物治疗[J],中国乡村医药,2001,8(1:)8-11
[10]谭新华,何清湖,尿癃康治疗前列腺增生40例临床观察[J],湖南中医杂志,1997,13(5):16.
[11]陈铭,王峻,崔学教教授治疗前列腺增生症经验介绍[J],新中医,2004,12(12):13-14.
[12]王和权,大黄北芪汤治疗前列腺增生25例[J],中国中医急症,2006,11(11):1289-1290.
[13]王为向,益肾通闭汤治疗前列腺增生30例[J],河北中医,2006,11(11):862.
[14]赵建业,高展翔,化瘀五法治疗前列腺增生症[J],福建中医学院学报,2004,14(3):12-13
[15]艾长山.前列腺增生的中医证治[J].中国乡村医生杂志,2000,(2):35-36
[16]方铁生,时永华.虚实分证论治前列腺增生症150例[J].南京中医药大学学报,1997,13(4):206-207
[17]吴国欣,林跃鑫,欧敏锐,等.白芥子提取物抑制前列腺增生的实验研究[J].中国中药杂志,2002,27(10):766-768
[18]贾金铭,孙利民,王勒榆,等,消癃通闭胶囊对大鼠前列腺组织成纤维细胞生长因子表达的影响[J],中国中西医结合杂志,1999,5(2):67
[19]张蜀武,常德贵,王久源,等.通关胶囊对离体人增生前列腺α_1-AR的拮抗作用[J].中华男科学,2001,7(2):136-138,140
[20]许国振,崔金涛.决闭胶囊与保列治抗实验性前列腺增生作用的比较研究[J].中国中医药科技.2003,10(1):9-10
[21]吴阶平主编,吴阶平泌尿外科学[M],第1版,济南:山东科学 技术出版社,2005,1:1131-1135
[22]谢庆祥,汪鸿,林福地,等,生长调控因子异常与良性前列腺增生的关系[J],中华泌尿外科杂志,2001,22(9):520-522.
[23]Hahn.Daniela.Simak Reiner.Steiner george et al.Expression of the VEGF-Receptor FIL-1 in benign.Premalignant and malignant prostate tissues[J].J Urol,2000,164(2):506-510.
[24]Sinowatz F,Schams D.Einspanier R,et al.Cellular localization of fibroblast growth factor 2(FGF-2) in benign prostatic hyperplasia[J].Histol histopathol,2000,15(2):475-481.
[25]Polnaszek N,Kwabi-Addo B.Wang J,lttmann M.FGFI7 is an 8Iltocrine prostatic epithelial growth factor and is upregnlated in benign prostatic hyperplasia[J].Prostate,2004,50(I):18-24.
[26]Smith P,Rhodes NP.Ke Y.Foster CS.Upregulation of estrogen and androgen receptors modulate expression of FGF-2 and FGF-7 in human.Cultured,prostatic stromal cells exposed to high concentrations esradiol[J].Prostate Cancer Prostatic Dis,2002,5(2):105-110.
[27]Castro P.Xia C.Gomez L.Lamb DJ.Ittmann M.Interleukin-8expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasia[J].Prostate,2004,60(2):153-159.
[28]Giri D.Ittmann M.Interleukin-1 alpha is a paracrine inducer of FGF-7,a key epithelial growth factor in benign prostatic hyperplasia[J].Am Pathol,2000,157(1):249-255.
[29]Castro P.Giri D.Lamb D.Ittmann M.Cellular senescence in the pathogenesis of benign prostatic hyperplasia[J].Prostate,2003,55(1):30-38.
[30]RobeMs,Rosebud,Jacobsom Debm J.Girman.Cynthia J,et al.Insulin-like growth factor 1,Insulin-~ke growth factor binding protein.and Urologic measures of benign prostatic hyperplasis[J].Epidemiology,2003,157(9):784-791.
[31]Konno-Takahashi N,Takeuchi T.Shimizu et al.Engineered IGF -I expression induces glandular enlargement in the murineprostate[J].J Endocrinol,2003,177(3):389-398.
[32]谢庆祥,刘春晓,姚华强,等.bFGF,EGFR和ABS在前列腺增生组织中表达的意义[J].中华泌尿外科杂志,1997,6(18):373.
[33]Zeng L.Rowland RG Lele SM.Kyprianou N.Apoptosis incidence and protein expression of p53,TGF-beta receptor Ⅱ.P27 kip and smad4 in benign,Premalignant human prostate[J],Hum Pathol,2004,35(3):290-297.
[34]Hong J,Song C.Shin Y,et al.Estrogen induction of smooth muscle differentiation of human prostatic stromal cells is mediated by transforming growth facctor-[beta][J].J Urol,2004,17(15):1865-1869.
[35] Huang X. Lee C. Regulation of stromal proliferation, growth arrest.differentiation and apoptosis in benign prostatic hyperplasia by TGF-beta[J]. Front Biosci,2003,1(8):740-749.
[36] Lee, Keith L, pEEHl. Donna M. Molecuar and cellular pathogenesis of benign prostatic hyperplasia[J].2004,172(5):1784 - 1791.
[37] Kypfianou N, TUHC. Jacobs SC. Apoptotic versus pmlifemtic aetivitiesin human BPH[J]. Hum Pathol, 1996, 27: 668-675.
[38] Kyprianou N, TuH, Jacobs SC. Apoptotic VenUS protiferatice a ctivities in human benign prostatic hyperplasia. J urol2007; 158:212
[39] Royuela M, De Miguel MR Bethencourt FR, et al. IL-2 its receptors.and bcl-2 and bax genes in normal. Hyerplastic and carcinomatous human prostates: immunohistochemical comparative analysis[J].Growth Factors,2000,18(2):135-146.
[40] hEGARTY. Paul K, Watson R. William G, et al. Effects of cyclic stretch on prostatic cells in culture [J]. J Urol,2002,168(5):2291-2295.
[41] Badawi. Alaa F, Liu Ying yin, Eledden, Mazen B, et al.Age-associated changes in the expression pattem of cyclooxygenase-2 and related apoptotic markers in the cancer suseptible region of rat prostate [J]. Carcinogenesis,2004,25(9):1681-1688.
[42]Wang W.Bergh A.Damber JE.Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2[J].Bcl-2 and cell proliferation in the glandular epithelium.Prostate,2004,61(1):60-72.
[43]贾彬,蔡文清,黎伟,等.雌激素对前列腺增生症移行区细胞Bcl-2,Bax和C-mye基因表达的影响[J].中华实验外科杂志,2004,21(1):77-78.
[44]蒋先镇,汤育新.雄激素与前列腺疾病[J].中国男科学杂志,2007,21(4):65-68.
[45]谢庆祥.汪鸿.缪友仁,等.细胞凋亡相关基因Bcl-2和Bax在前列腺增生织中表达的意义.中华泌尿外科杂志1998:19(2):98
[46]Gandour-Edwards R.Mack PC.Devere-White RW,et al.Abnormalities of apoptotic and cell cycle regulatory proteins in distinct histopathologic components of benign prostatic hyperplasia [J].Prostate Cancer Prostatic Dis,2004,17(10):1038-1041.
[47]杨金瑞,黄循,杨竹林.前列腺增生和前列腺癌组织细胞凋亡及Bcl-2、Bax基因表达的研究[J].中华泌尿外科杂志,2000,21(8):485-487.
[48]Sasaki Y,AhmedH.Takeuchi T,et al.Immunohistochemical study of Fas.Fas ligand and interleukin-1 βconverting enzyme expression in human prostatic cancer[J].Br J Urol,1998,81:852-855.
[49]Marcelli M,Shao.T.C,Li Xiao Ying,et al.Induction of apoptosis in benign stromal cells by adenoviral-mediated overexpression of caspase-7[J]J Urol,2000,164(2):518-525.
[50]邓春华,丘少鹏,陈辉熔,等.Caspase-3在前列腺组织中的表达和意义[J].中国男科学杂志,2003,17(4):224-228.
[51]Ho,Mat H;Bhatia,Narender N;Khorram,Omid.Physiologic role of nitric oxide synthase in female lower urinary tract[J].J Uril,2004,16(5):423-429.
[52]Royle,Justine Sarah:Ross.James A:Ansell.Lan,et al.Nitric oxide donating nonsteroidal anti-inflammatory drugs induce apoptosis in human prostate cancer cell systems and human prostatic stroma via caspase-3[J].J Urol,2004,172(1):338-344.
[53]文秀英,徐保国,等,穿山甲对心肌收缩功能和血小板聚集性的影响[J],中国中药杂志,1999,24(1):51-52
[54]周孜.丹参药理作用及临床应用[J].中西医结合杂志,1990,10(4):242
[55]金惠铭.病理生理学[M].北京:人民卫生出版社,第六版,2001:1-182.
[56]祝海,孙小庆,周荣祥,等.凋亡抑制基因bcl-2在前列腺组织中的表达[J].中华泌尿外科杂志,2002,23(5):301-303.
[57]Colombel m,Vacherot F,Diez SG,et al.Zonal variation of apoptosis and proliferation in the mormal prostase and in benign prostatic hyperpla-Sia.Br J urol,1998,82:380-385.
[58]Kyprianou N,Tull,Jacobs SC.Apoptotic versus protiferatice a ctivities in human benign prostatic hyperplasia.J urol,1997,158:212-216.
[59]邓方明,顾方六,夏同礼,等.人良性前列腺增生细胞增殖和凋亡状态的研究[J].中华外科杂志,1996,34:620.
[60]谢庆祥,汪鸿,缪友仁,等.细胞凋亡相关基因bcl-2和bax在前列腺增生组织中表达的意义[J].中华泌尿外科杂志,1998,19(2):98-100.
[61]郑德先.细胞凋亡的研究进展[J].中华病理学杂志,1996,25:50.
1.吴国欣,林跃鑫,欧敏锐,等.白芥子提取物抑制前列腺增生的实验研究[J].中国中药杂志,2002,27(10):766-768
2.谭毓治,伍爱婵,叶勇,等.榆白皮抗前列腺增生和抗炎作用研究[J].中药药理与临床,2003,19(1):21-22
3.董能本,詹炳炎,夏炎森,等.补骨脂素抗良性前列腺增生的研究[J].中华实验外科杂志,2003,20(2):109-110
4.李百文,王知侠,许金玉,等.土贝母皂甙对大鼠前列腺增生模型影响的实验研究[J].中国男科学杂志,2003,17(3):168-169
5.杜旭,窦秋莲,李春艳,等.黑龙江葵花粉治疗前列腺增生的药效学研究[J].中国中医药科技,2002,9(2):94-95
6.李明志,任国峰,黄忆明,等.大豆异黄酮对前列腺增生大鼠血清PAP的影响[J].实用预防医学,2003,10(5):650-651
7.孟学强,许东晖,梅雪婷,等.海马胶囊治疗实验性前列腺增生的研究[J].中国药学杂志,2005,40(3):190-193.
8.朱宏建,南勋义,党建功,等.中药苦参和南瓜子对前列腺增生影响的实验研究[J].中国中西医结台外科杂志,1999,5(4):258-261
9.李承军,陈玉英,刘瑞华,等.消癃通闭胶囊抑制大鼠前列腺增生作用的研究[J].中成药,1995,17(6):30-33.
10.贾金铭,刘鼎新,李寅增,等.消癃通闭对小鼠前列腺上皮细胞DNA合成的影响[J].中华泌尿外科杂志,1997,18(1):18-20.
11.隋艳华,谢红,安邦权,等.前列舒片抑制前列腺增生及抗炎症作用[J].山东中医学院学报,1996,20(4):272-274.
12.武继彪,于树玲,倪培忠.前列康宝的药理学研究[J].时珍国药研究,1997,8(5):414-415.
13.刘敏,张士勇.三妙散对大、小鼠前列腺增生模型作用的实验研究[J].基层中药杂志,2001,16(4):3-7.
14.徐瑜玲,苗明三.前列康栓对前列腺增生小鼠的预防和治疗作用[J].中国中医药科技,2003,10(5):282-283.
15.马骏,任远,金辉,等.前列安对前列腺增生和前列腺炎的抑制作用[J].甘肃中医学院学报,2002,19(1):13-17
16.黄小波,李宗信,李斌,等.消癃合剂对丙酸睾丸酮诱发小鼠前列腺增生作用的研究[J].北京中医药大学学报,2002,25(6):37-39
17.叶加,李长龄,吴恩融,等.IPH抗实验性前列腺增生的研究[J].中国药学杂志,2002,37(12):906-910
18.马清钧.李宏杰,孙曙光,等.乾列安胶囊对肾阳亏虚型前列腺增生症影响的研究[J].中医药学刊,2003,21(4):530-531
19.廖泽云,邓丽群,黄德彬,等.前列冲剂对大鼠前列腺增生影响的实验研究[J].湖北民族学院学报·医学版,2004,21(3):16-18
20.刘洋,安利文.中医药治疗良性前列腺增生机理的研究进展与现状[J].中国男科学杂志,2006,20(6):71-72
21.张蜀武,常德贵,王久源,等.通关胶囊对离体人增生前列腺α1-AR的拮抗作用[J].中华男科学,2001,7(2):136-138,140
22.许国振,崔金涛.决闭胶囊与保列治抗实验性前列腺增生作用的比较研究 [J].中国中医药科技.2003,10(1):9-10
23.曾政光,邵继春,于军桥,等.中医药治疗前列腺增生作用机理的研究概况[J].中国中西医结合外科杂志.2002,8(2):129-130
24.李秀掸,何光星,黄霞,等.益肾固泉液抗前列腺增生及解痉作用研究[J].生理科学杂志,2000,22(3):25-28
25.袁飞锋,陈胜辉,罗萍萍,等.前列腺康复胶囊抑制前列腺增生的实验研究[J].时珍国医国药,2000,11(7):577-578
26.张亚大,卢子杰,张平,等.益肾逐瘀汤治疗良性前列腺增生症100例疗效观察及对性激素的影响[J].新中医,2003.35(9):14-15
27.张凯,杨新宇,张军,等.泽桂癃爽胶囊治疗良性前列腺增生疗效和作用机理的初步研究[J].中华泌尿外科杂志,2003,24(6):388-390
28.曹继刚,周安方.仙甲汤对前列腺增生大鼠前列腺组织EGF,TGF-β1表达影响的研究[J].中医药学刊,2004,22(9):1661-1662
29.米振国,刘素香,曹永勤,等.益气通淋冲剂对大鼠前列腺增生组织生长因子的调节作用[J].中国中药杂志,2003,28(7):653-655
[1]武忠弼,杨光华主编.中华外科病理学[M].第1版,北京:人民卫生出版社,2002,8:1154-1155.
[2]Kyprianou N,TUHC.Jacobs SC.Apoptotic versus proliferatic activities in human BPH[J].Hum Pathol,1996,27:668-675.
[3]Eaton.Colby L.Aetiology and pathogenesis prostatic hyperplasia[J].Urology,1993,13(1):7-10
[4]Kerr JFR,Wylie AH.Currie AR.Apoptosis:a basic biological phenomenon with wide-ranging inplications in tissue kinetics[J].Br J Cancer,1972,26:239-257.
[5]Barrack ER.Berry SJ.DNA synthesis in the canine Prostate;Effects of androgen andl estrogen treatment.Prostate,1987,10:45
[6]胡野,凌志强,单小云编著.细胞凋亡的分子医学[J].第1版,北京:军事科学出版社,2002,8(1):3-9.
[7]Royuela M,De Miguel MP.Bethencourt FR,et al.IL-2 its receptots.and bcl-2 and bax genes in normal,hyperplastic and carcinomatous human prostates:immunohistocbemical comparative analysis[J].Growth Factors,2000,18(2):135-146.
[8]hEGARTY.Paul K,Watson R.William G,et al.Efects of cyclic stretch on prostatic cells in culture[J].J Urol,2002,168(5):2291-2295.
[9]Badawi.Alaa F,liu Ying yin,Eledden,MasenB,et al.Age-associated changes in the expression pattern of cyclooxygenase-2 and related apoptotic markers in the cancer suseptible region of rat prostate[J].Carcinogenesis,2004,25(9):1681-1688.
[10]Wang W.Bergh A.Damber JE.Chronic inflammation in benign prostate hyporplasia is associated with focal upregulation of cyclooxygenase-2[J].Bcl-2 and cell proliferation in the glandular epithelium.Prostate,2004,61(1):60-72.
[11]贾彬,蔡文清,黎伟,等.雌激素对前列腺增生症移行区细胞Bcl-2、Bax 和C-myc基因表达的影响[J].中华实验外科杂志,2004,21(1):77-78.
[12]Gandour-Edwards R,Mack PC.Devere-White RW.et al.Abnormalities of apoptotic and cell cycle regulatory proteins in distinct histopathologic components of benign prostatic hyporplasia[J].Prostate Cancer Prostatic Dis,2004,17(10):1038-1041.
[13]杨金瑞,黄循,杨竹林.前列腺增生和前列腺癌组织细胞凋亡及Bcl-2、Bax 基因表达的研究[J].中华泌尿外科杂志,2000,21(8):485-487.
[14]邓方明,顾方六,夏同礼,等.癌蛋白bcl-2在前列腺增生组织中的表达及其意义.中华泌尿外科杂志,1995,16(12):729-731
[15]谢庆翔,汪鸿,廖友仁,等.细胞凋亡相关基因bcl-2和bax在前列腺增生组织中表达的意义.中华泌尿外科杂志,1998,19(2):98-100
[16]Marc Colombel.Carl A.Olssom,et al.Hormone-regulated Apoptosis results from reentry of diferentiated prosate[J].Cancer Res,1992,52:4313-4319.
[17]Richard R,Berges.Yuzo Furuya,et al.Call proliferation DNA repair,and p53 function are not required for programmed d death of prostatic glandular cells induced by androgen ablation[J].Proc Natl Acad Sci USA.1993,90:8910-8914.
[18]Sasaki Y,Ahmed H.Takeuchi T,et al.Immunohistoche mical study of Fas.Fas ligand and interleukin-1 βconverting enzyme expression in human prostatic cancer[J].Br J Urol,1998,81:852-855.
[19]Marcelli M,Shao.T.C,Li Xiao Ying,et al.Induction of apoptosis in benign stromal cells by adenoviral-mediated overexpression of caspase-7[J].J Urel.2000,164(2):518-525.
[20]邓春华,丘少鹏,陈辉熔,等.Caspase-3在前列腺组织中的表达和意义[J].中国男科学杂志,2003,17(4):224-228.
[21]Collmbel M,Vacherot,F,Gil Diez S,et al.Zonal variation of apoptosis and proliferation in the normal prostate and in benign prostatic hyperplasia.BritJ Urol 1998;82:280
[22]Kyprianou N,Tu H,Jaoobs SC.Aoptotic versus proliferative Activities in human benign prostatic hyperplasia.Human Pathol 1996;27:668
[23]Royle,Justine Sarah:Ross.James A:Ansell.lan,et al.Nitric oxide donating nonsteroidal anti-inflammatory drugs induce apoptosis in human prostate cancer cell systems and human prostatic stroma via caspose-3[J].J Urol,2004,172(1):338-344.
[24]Ho,Mat H;Bhatia,Narender N;Khorram,Omid.Physiologic role of nitric oxide synthase in female lower urinary tract[J].J Uri1,2004,16(5):423-429.
[25]Grandini R,Realacci M,Di Silverio F,et al.Nitric oxide synthases in normal and henign hyperplasia human prostate:immunohistochemistry and molecular biology[J].J Pathol.1999,189:221-219
[26]Crone JK,Burnett AL,Chamness SL,et al.Neuronal nitrieoxide synthase in the canine prostate:ageing,sex,steroid and pathology correlations[J].J Androl,1998,19:358
[27]贾金铭,马春涛,王勒渝,等.中药消癃通闭对大鼠前列腺平滑肌一氧化氮合酶及上皮细胞凋亡的影响[J].中国中西医结合杂志,2002,22:196-199.
[28]Kyprianou N,Isaas JT.Activition of PCD in the rat ventral prostate after castration[J].Endocrindogy,1998,122:552-562.
[29]Westin P,Brandstron A.Damber JE,et al.Castration plus oestrogen treatment indues but castration alone suppresses epithelial cell apoptosis in an androgen-sensitive rat prostatic adenocareinoma[J].Br J Cancer,1995,72:140-145.
[30]Buttyan,Ralph:Ghafar.Mohamed A:Shabsigh.Ahmad.The effects of androgen deprivation on the prostate glnd:cell death mediated by vascular regression[J].Urology,2000:10(5):415-420.
[31]Hong J.Sogn C,Shin Y,et al.Estrogen induction of smooth muscle differentiation of human prostatic stromal cells is mediated by transforming growth factor-[beta][J].J Urol,2004,171(5):1965-1969.
[2]国际协调委员会有关前列腺疾病患者诊断和治疗方法的推荐意见[J].中华泌尿外科杂志,1997,9(3):230-235.
[3]吴阶平.泌尿外科学[M].济南:山东科学技术出版社,2005,1125-1172
[4]鄂征,组织培养和分子细胞学技术[M],北京:北京出版社,2001:35-38
[5]司徒镇强,吴军正.,细胞培养[M],西安:兴界图书出版,2003:22-77
[6]孙明,杨宇如,李虹,等.多西紫杉醇对激素非依赖性前列腺癌的体内外作用研究[J],中国男科学杂志,2004,18(5):14-16
[7]刘文革,林佳俊,王锋等,RT-PCR检测bFGF对脊髓损伤后bcl-2、bax基因的表达[J],福建医科大学学报,2005,39(3):281-283
[8]柯梦笔,前列平胶囊治疗前列腺增生46例[J],广西中医药杂志,1996,17(2):22
[9]鲍镇美,良性前列腺增生的药物治疗[J],中国乡村医药,2001,8(1:)8-11
[10]谭新华,何清湖,尿癃康治疗前列腺增生40例临床观察[J],湖南中医杂志,1997,13(5):16.
[11]陈铭,王峻,崔学教教授治疗前列腺增生症经验介绍[J],新中医,2004,12(12):13-14.
[12]王和权,大黄北芪汤治疗前列腺增生25例[J],中国中医急症,2006,11(11):1289-1290.
[13]王为向,益肾通闭汤治疗前列腺增生30例[J],河北中医,2006,11(11):862.
[14]赵建业,高展翔,化瘀五法治疗前列腺增生症[J],福建中医学院学报,2004,14(3):12-13
[15]艾长山.前列腺增生的中医证治[J].中国乡村医生杂志,2000,(2):35-36
[16]方铁生,时永华.虚实分证论治前列腺增生症150例[J].南京中医药大学学报,1997,13(4):206-207
[17]吴国欣,林跃鑫,欧敏锐,等.白芥子提取物抑制前列腺增生的实验研究[J].中国中药杂志,2002,27(10):766-768
[18]贾金铭,孙利民,王勒榆,等,消癃通闭胶囊对大鼠前列腺组织成纤维细胞生长因子表达的影响[J],中国中西医结合杂志,1999,5(2):67
[19]张蜀武,常德贵,王久源,等.通关胶囊对离体人增生前列腺α_1-AR的拮抗作用[J].中华男科学,2001,7(2):136-138,140
[20]许国振,崔金涛.决闭胶囊与保列治抗实验性前列腺增生作用的比较研究[J].中国中医药科技.2003,10(1):9-10
[21]吴阶平主编,吴阶平泌尿外科学[M],第1版,济南:山东科学 技术出版社,2005,1:1131-1135
[22]谢庆祥,汪鸿,林福地,等,生长调控因子异常与良性前列腺增生的关系[J],中华泌尿外科杂志,2001,22(9):520-522.
[23]Hahn.Daniela.Simak Reiner.Steiner george et al.Expression of the VEGF-Receptor FIL-1 in benign.Premalignant and malignant prostate tissues[J].J Urol,2000,164(2):506-510.
[24]Sinowatz F,Schams D.Einspanier R,et al.Cellular localization of fibroblast growth factor 2(FGF-2) in benign prostatic hyperplasia[J].Histol histopathol,2000,15(2):475-481.
[25]Polnaszek N,Kwabi-Addo B.Wang J,lttmann M.FGFI7 is an 8Iltocrine prostatic epithelial growth factor and is upregnlated in benign prostatic hyperplasia[J].Prostate,2004,50(I):18-24.
[26]Smith P,Rhodes NP.Ke Y.Foster CS.Upregulation of estrogen and androgen receptors modulate expression of FGF-2 and FGF-7 in human.Cultured,prostatic stromal cells exposed to high concentrations esradiol[J].Prostate Cancer Prostatic Dis,2002,5(2):105-110.
[27]Castro P.Xia C.Gomez L.Lamb DJ.Ittmann M.Interleukin-8expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasia[J].Prostate,2004,60(2):153-159.
[28]Giri D.Ittmann M.Interleukin-1 alpha is a paracrine inducer of FGF-7,a key epithelial growth factor in benign prostatic hyperplasia[J].Am Pathol,2000,157(1):249-255.
[29]Castro P.Giri D.Lamb D.Ittmann M.Cellular senescence in the pathogenesis of benign prostatic hyperplasia[J].Prostate,2003,55(1):30-38.
[30]RobeMs,Rosebud,Jacobsom Debm J.Girman.Cynthia J,et al.Insulin-like growth factor 1,Insulin-~ke growth factor binding protein.and Urologic measures of benign prostatic hyperplasis[J].Epidemiology,2003,157(9):784-791.
[31]Konno-Takahashi N,Takeuchi T.Shimizu et al.Engineered IGF -I expression induces glandular enlargement in the murineprostate[J].J Endocrinol,2003,177(3):389-398.
[32]谢庆祥,刘春晓,姚华强,等.bFGF,EGFR和ABS在前列腺增生组织中表达的意义[J].中华泌尿外科杂志,1997,6(18):373.
[33]Zeng L.Rowland RG Lele SM.Kyprianou N.Apoptosis incidence and protein expression of p53,TGF-beta receptor Ⅱ.P27 kip and smad4 in benign,Premalignant human prostate[J],Hum Pathol,2004,35(3):290-297.
[34]Hong J,Song C.Shin Y,et al.Estrogen induction of smooth muscle differentiation of human prostatic stromal cells is mediated by transforming growth facctor-[beta][J].J Urol,2004,17(15):1865-1869.
[35] Huang X. Lee C. Regulation of stromal proliferation, growth arrest.differentiation and apoptosis in benign prostatic hyperplasia by TGF-beta[J]. Front Biosci,2003,1(8):740-749.
[36] Lee, Keith L, pEEHl. Donna M. Molecuar and cellular pathogenesis of benign prostatic hyperplasia[J].2004,172(5):1784 - 1791.
[37] Kypfianou N, TUHC. Jacobs SC. Apoptotic versus pmlifemtic aetivitiesin human BPH[J]. Hum Pathol, 1996, 27: 668-675.
[38] Kyprianou N, TuH, Jacobs SC. Apoptotic VenUS protiferatice a ctivities in human benign prostatic hyperplasia. J urol2007; 158:212
[39] Royuela M, De Miguel MR Bethencourt FR, et al. IL-2 its receptors.and bcl-2 and bax genes in normal. Hyerplastic and carcinomatous human prostates: immunohistochemical comparative analysis[J].Growth Factors,2000,18(2):135-146.
[40] hEGARTY. Paul K, Watson R. William G, et al. Effects of cyclic stretch on prostatic cells in culture [J]. J Urol,2002,168(5):2291-2295.
[41] Badawi. Alaa F, Liu Ying yin, Eledden, Mazen B, et al.Age-associated changes in the expression pattem of cyclooxygenase-2 and related apoptotic markers in the cancer suseptible region of rat prostate [J]. Carcinogenesis,2004,25(9):1681-1688.
[42]Wang W.Bergh A.Damber JE.Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2[J].Bcl-2 and cell proliferation in the glandular epithelium.Prostate,2004,61(1):60-72.
[43]贾彬,蔡文清,黎伟,等.雌激素对前列腺增生症移行区细胞Bcl-2,Bax和C-mye基因表达的影响[J].中华实验外科杂志,2004,21(1):77-78.
[44]蒋先镇,汤育新.雄激素与前列腺疾病[J].中国男科学杂志,2007,21(4):65-68.
[45]谢庆祥.汪鸿.缪友仁,等.细胞凋亡相关基因Bcl-2和Bax在前列腺增生织中表达的意义.中华泌尿外科杂志1998:19(2):98
[46]Gandour-Edwards R.Mack PC.Devere-White RW,et al.Abnormalities of apoptotic and cell cycle regulatory proteins in distinct histopathologic components of benign prostatic hyperplasia [J].Prostate Cancer Prostatic Dis,2004,17(10):1038-1041.
[47]杨金瑞,黄循,杨竹林.前列腺增生和前列腺癌组织细胞凋亡及Bcl-2、Bax基因表达的研究[J].中华泌尿外科杂志,2000,21(8):485-487.
[48]Sasaki Y,AhmedH.Takeuchi T,et al.Immunohistochemical study of Fas.Fas ligand and interleukin-1 βconverting enzyme expression in human prostatic cancer[J].Br J Urol,1998,81:852-855.
[49]Marcelli M,Shao.T.C,Li Xiao Ying,et al.Induction of apoptosis in benign stromal cells by adenoviral-mediated overexpression of caspase-7[J]J Urol,2000,164(2):518-525.
[50]邓春华,丘少鹏,陈辉熔,等.Caspase-3在前列腺组织中的表达和意义[J].中国男科学杂志,2003,17(4):224-228.
[51]Ho,Mat H;Bhatia,Narender N;Khorram,Omid.Physiologic role of nitric oxide synthase in female lower urinary tract[J].J Uril,2004,16(5):423-429.
[52]Royle,Justine Sarah:Ross.James A:Ansell.Lan,et al.Nitric oxide donating nonsteroidal anti-inflammatory drugs induce apoptosis in human prostate cancer cell systems and human prostatic stroma via caspase-3[J].J Urol,2004,172(1):338-344.
[53]文秀英,徐保国,等,穿山甲对心肌收缩功能和血小板聚集性的影响[J],中国中药杂志,1999,24(1):51-52
[54]周孜.丹参药理作用及临床应用[J].中西医结合杂志,1990,10(4):242
[55]金惠铭.病理生理学[M].北京:人民卫生出版社,第六版,2001:1-182.
[56]祝海,孙小庆,周荣祥,等.凋亡抑制基因bcl-2在前列腺组织中的表达[J].中华泌尿外科杂志,2002,23(5):301-303.
[57]Colombel m,Vacherot F,Diez SG,et al.Zonal variation of apoptosis and proliferation in the mormal prostase and in benign prostatic hyperpla-Sia.Br J urol,1998,82:380-385.
[58]Kyprianou N,Tull,Jacobs SC.Apoptotic versus protiferatice a ctivities in human benign prostatic hyperplasia.J urol,1997,158:212-216.
[59]邓方明,顾方六,夏同礼,等.人良性前列腺增生细胞增殖和凋亡状态的研究[J].中华外科杂志,1996,34:620.
[60]谢庆祥,汪鸿,缪友仁,等.细胞凋亡相关基因bcl-2和bax在前列腺增生组织中表达的意义[J].中华泌尿外科杂志,1998,19(2):98-100.
[61]郑德先.细胞凋亡的研究进展[J].中华病理学杂志,1996,25:50.
1.吴国欣,林跃鑫,欧敏锐,等.白芥子提取物抑制前列腺增生的实验研究[J].中国中药杂志,2002,27(10):766-768
2.谭毓治,伍爱婵,叶勇,等.榆白皮抗前列腺增生和抗炎作用研究[J].中药药理与临床,2003,19(1):21-22
3.董能本,詹炳炎,夏炎森,等.补骨脂素抗良性前列腺增生的研究[J].中华实验外科杂志,2003,20(2):109-110
4.李百文,王知侠,许金玉,等.土贝母皂甙对大鼠前列腺增生模型影响的实验研究[J].中国男科学杂志,2003,17(3):168-169
5.杜旭,窦秋莲,李春艳,等.黑龙江葵花粉治疗前列腺增生的药效学研究[J].中国中医药科技,2002,9(2):94-95
6.李明志,任国峰,黄忆明,等.大豆异黄酮对前列腺增生大鼠血清PAP的影响[J].实用预防医学,2003,10(5):650-651
7.孟学强,许东晖,梅雪婷,等.海马胶囊治疗实验性前列腺增生的研究[J].中国药学杂志,2005,40(3):190-193.
8.朱宏建,南勋义,党建功,等.中药苦参和南瓜子对前列腺增生影响的实验研究[J].中国中西医结台外科杂志,1999,5(4):258-261
9.李承军,陈玉英,刘瑞华,等.消癃通闭胶囊抑制大鼠前列腺增生作用的研究[J].中成药,1995,17(6):30-33.
10.贾金铭,刘鼎新,李寅增,等.消癃通闭对小鼠前列腺上皮细胞DNA合成的影响[J].中华泌尿外科杂志,1997,18(1):18-20.
11.隋艳华,谢红,安邦权,等.前列舒片抑制前列腺增生及抗炎症作用[J].山东中医学院学报,1996,20(4):272-274.
12.武继彪,于树玲,倪培忠.前列康宝的药理学研究[J].时珍国药研究,1997,8(5):414-415.
13.刘敏,张士勇.三妙散对大、小鼠前列腺增生模型作用的实验研究[J].基层中药杂志,2001,16(4):3-7.
14.徐瑜玲,苗明三.前列康栓对前列腺增生小鼠的预防和治疗作用[J].中国中医药科技,2003,10(5):282-283.
15.马骏,任远,金辉,等.前列安对前列腺增生和前列腺炎的抑制作用[J].甘肃中医学院学报,2002,19(1):13-17
16.黄小波,李宗信,李斌,等.消癃合剂对丙酸睾丸酮诱发小鼠前列腺增生作用的研究[J].北京中医药大学学报,2002,25(6):37-39
17.叶加,李长龄,吴恩融,等.IPH抗实验性前列腺增生的研究[J].中国药学杂志,2002,37(12):906-910
18.马清钧.李宏杰,孙曙光,等.乾列安胶囊对肾阳亏虚型前列腺增生症影响的研究[J].中医药学刊,2003,21(4):530-531
19.廖泽云,邓丽群,黄德彬,等.前列冲剂对大鼠前列腺增生影响的实验研究[J].湖北民族学院学报·医学版,2004,21(3):16-18
20.刘洋,安利文.中医药治疗良性前列腺增生机理的研究进展与现状[J].中国男科学杂志,2006,20(6):71-72
21.张蜀武,常德贵,王久源,等.通关胶囊对离体人增生前列腺α1-AR的拮抗作用[J].中华男科学,2001,7(2):136-138,140
22.许国振,崔金涛.决闭胶囊与保列治抗实验性前列腺增生作用的比较研究 [J].中国中医药科技.2003,10(1):9-10
23.曾政光,邵继春,于军桥,等.中医药治疗前列腺增生作用机理的研究概况[J].中国中西医结合外科杂志.2002,8(2):129-130
24.李秀掸,何光星,黄霞,等.益肾固泉液抗前列腺增生及解痉作用研究[J].生理科学杂志,2000,22(3):25-28
25.袁飞锋,陈胜辉,罗萍萍,等.前列腺康复胶囊抑制前列腺增生的实验研究[J].时珍国医国药,2000,11(7):577-578
26.张亚大,卢子杰,张平,等.益肾逐瘀汤治疗良性前列腺增生症100例疗效观察及对性激素的影响[J].新中医,2003.35(9):14-15
27.张凯,杨新宇,张军,等.泽桂癃爽胶囊治疗良性前列腺增生疗效和作用机理的初步研究[J].中华泌尿外科杂志,2003,24(6):388-390
28.曹继刚,周安方.仙甲汤对前列腺增生大鼠前列腺组织EGF,TGF-β1表达影响的研究[J].中医药学刊,2004,22(9):1661-1662
29.米振国,刘素香,曹永勤,等.益气通淋冲剂对大鼠前列腺增生组织生长因子的调节作用[J].中国中药杂志,2003,28(7):653-655
[1]武忠弼,杨光华主编.中华外科病理学[M].第1版,北京:人民卫生出版社,2002,8:1154-1155.
[2]Kyprianou N,TUHC.Jacobs SC.Apoptotic versus proliferatic activities in human BPH[J].Hum Pathol,1996,27:668-675.
[3]Eaton.Colby L.Aetiology and pathogenesis prostatic hyperplasia[J].Urology,1993,13(1):7-10
[4]Kerr JFR,Wylie AH.Currie AR.Apoptosis:a basic biological phenomenon with wide-ranging inplications in tissue kinetics[J].Br J Cancer,1972,26:239-257.
[5]Barrack ER.Berry SJ.DNA synthesis in the canine Prostate;Effects of androgen andl estrogen treatment.Prostate,1987,10:45
[6]胡野,凌志强,单小云编著.细胞凋亡的分子医学[J].第1版,北京:军事科学出版社,2002,8(1):3-9.
[7]Royuela M,De Miguel MP.Bethencourt FR,et al.IL-2 its receptots.and bcl-2 and bax genes in normal,hyperplastic and carcinomatous human prostates:immunohistocbemical comparative analysis[J].Growth Factors,2000,18(2):135-146.
[8]hEGARTY.Paul K,Watson R.William G,et al.Efects of cyclic stretch on prostatic cells in culture[J].J Urol,2002,168(5):2291-2295.
[9]Badawi.Alaa F,liu Ying yin,Eledden,MasenB,et al.Age-associated changes in the expression pattern of cyclooxygenase-2 and related apoptotic markers in the cancer suseptible region of rat prostate[J].Carcinogenesis,2004,25(9):1681-1688.
[10]Wang W.Bergh A.Damber JE.Chronic inflammation in benign prostate hyporplasia is associated with focal upregulation of cyclooxygenase-2[J].Bcl-2 and cell proliferation in the glandular epithelium.Prostate,2004,61(1):60-72.
[11]贾彬,蔡文清,黎伟,等.雌激素对前列腺增生症移行区细胞Bcl-2、Bax 和C-myc基因表达的影响[J].中华实验外科杂志,2004,21(1):77-78.
[12]Gandour-Edwards R,Mack PC.Devere-White RW.et al.Abnormalities of apoptotic and cell cycle regulatory proteins in distinct histopathologic components of benign prostatic hyporplasia[J].Prostate Cancer Prostatic Dis,2004,17(10):1038-1041.
[13]杨金瑞,黄循,杨竹林.前列腺增生和前列腺癌组织细胞凋亡及Bcl-2、Bax 基因表达的研究[J].中华泌尿外科杂志,2000,21(8):485-487.
[14]邓方明,顾方六,夏同礼,等.癌蛋白bcl-2在前列腺增生组织中的表达及其意义.中华泌尿外科杂志,1995,16(12):729-731
[15]谢庆翔,汪鸿,廖友仁,等.细胞凋亡相关基因bcl-2和bax在前列腺增生组织中表达的意义.中华泌尿外科杂志,1998,19(2):98-100
[16]Marc Colombel.Carl A.Olssom,et al.Hormone-regulated Apoptosis results from reentry of diferentiated prosate[J].Cancer Res,1992,52:4313-4319.
[17]Richard R,Berges.Yuzo Furuya,et al.Call proliferation DNA repair,and p53 function are not required for programmed d death of prostatic glandular cells induced by androgen ablation[J].Proc Natl Acad Sci USA.1993,90:8910-8914.
[18]Sasaki Y,Ahmed H.Takeuchi T,et al.Immunohistoche mical study of Fas.Fas ligand and interleukin-1 βconverting enzyme expression in human prostatic cancer[J].Br J Urol,1998,81:852-855.
[19]Marcelli M,Shao.T.C,Li Xiao Ying,et al.Induction of apoptosis in benign stromal cells by adenoviral-mediated overexpression of caspase-7[J].J Urel.2000,164(2):518-525.
[20]邓春华,丘少鹏,陈辉熔,等.Caspase-3在前列腺组织中的表达和意义[J].中国男科学杂志,2003,17(4):224-228.
[21]Collmbel M,Vacherot,F,Gil Diez S,et al.Zonal variation of apoptosis and proliferation in the normal prostate and in benign prostatic hyperplasia.BritJ Urol 1998;82:280
[22]Kyprianou N,Tu H,Jaoobs SC.Aoptotic versus proliferative Activities in human benign prostatic hyperplasia.Human Pathol 1996;27:668
[23]Royle,Justine Sarah:Ross.James A:Ansell.lan,et al.Nitric oxide donating nonsteroidal anti-inflammatory drugs induce apoptosis in human prostate cancer cell systems and human prostatic stroma via caspose-3[J].J Urol,2004,172(1):338-344.
[24]Ho,Mat H;Bhatia,Narender N;Khorram,Omid.Physiologic role of nitric oxide synthase in female lower urinary tract[J].J Uri1,2004,16(5):423-429.
[25]Grandini R,Realacci M,Di Silverio F,et al.Nitric oxide synthases in normal and henign hyperplasia human prostate:immunohistochemistry and molecular biology[J].J Pathol.1999,189:221-219
[26]Crone JK,Burnett AL,Chamness SL,et al.Neuronal nitrieoxide synthase in the canine prostate:ageing,sex,steroid and pathology correlations[J].J Androl,1998,19:358
[27]贾金铭,马春涛,王勒渝,等.中药消癃通闭对大鼠前列腺平滑肌一氧化氮合酶及上皮细胞凋亡的影响[J].中国中西医结合杂志,2002,22:196-199.
[28]Kyprianou N,Isaas JT.Activition of PCD in the rat ventral prostate after castration[J].Endocrindogy,1998,122:552-562.
[29]Westin P,Brandstron A.Damber JE,et al.Castration plus oestrogen treatment indues but castration alone suppresses epithelial cell apoptosis in an androgen-sensitive rat prostatic adenocareinoma[J].Br J Cancer,1995,72:140-145.
[30]Buttyan,Ralph:Ghafar.Mohamed A:Shabsigh.Ahmad.The effects of androgen deprivation on the prostate glnd:cell death mediated by vascular regression[J].Urology,2000:10(5):415-420.
[31]Hong J.Sogn C,Shin Y,et al.Estrogen induction of smooth muscle differentiation of human prostatic stromal cells is mediated by transforming growth factor-[beta][J].J Urol,2004,171(5):1965-1969.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |